ES2159697T3 - Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida. - Google Patents
Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida.Info
- Publication number
- ES2159697T3 ES2159697T3 ES96400456T ES96400456T ES2159697T3 ES 2159697 T3 ES2159697 T3 ES 2159697T3 ES 96400456 T ES96400456 T ES 96400456T ES 96400456 T ES96400456 T ES 96400456T ES 2159697 T3 ES2159697 T3 ES 2159697T3
- Authority
- ES
- Spain
- Prior art keywords
- prurites
- treat
- liques
- cgrp antagonist
- composition obtained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940127597 CGRP antagonist Drugs 0.000 title abstract 2
- 239000003735 calcitonin gene related peptide receptor antagonist Substances 0.000 title abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
LA INVENCION SE REFIERE A LA UTILIZACION DE UN ANTAGONISTA DE CGRP EN UNA COMPOSICION COSMETICA, FARMACEUTICA O DERMATOLOGICA, PARTICULARMENTE DE APLICACION TOPICA PARA TRATAR LOS LIQUENES, LOS PRURIGOS, LAS TOXIDERMIAS PRURIGINOSAS Y LOS PRURITOS SEVEROS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9503627 | 1995-03-28 | ||
FR9503627A FR2732220B1 (fr) | 1995-03-28 | 1995-03-28 | Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2159697T3 true ES2159697T3 (es) | 2001-10-16 |
ES2159697T5 ES2159697T5 (es) | 2008-07-01 |
Family
ID=9477497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96400456T Expired - Lifetime ES2159697T5 (es) | 1995-03-28 | 1996-03-04 | Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida. |
Country Status (14)
Country | Link |
---|---|
US (1) | US5935586A (es) |
EP (1) | EP0734728B2 (es) |
JP (1) | JP3043610B2 (es) |
AR (1) | AR001435A1 (es) |
AT (1) | ATE201828T1 (es) |
BR (1) | BR9601467A (es) |
CA (1) | CA2172778C (es) |
DE (1) | DE69613168T3 (es) |
ES (1) | ES2159697T5 (es) |
FR (1) | FR2732220B1 (es) |
HU (1) | HUP9600764A3 (es) |
MX (1) | MX9601151A (es) |
PL (1) | PL313511A1 (es) |
RU (1) | RU2152785C1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
JP2001233764A (ja) * | 2000-02-22 | 2001-08-28 | Hisamitsu Pharmaceut Co Inc | N−置換−o−トルイジン誘導体からなる鎮痒剤 |
CA2495498C (en) | 2002-08-12 | 2014-04-15 | Birkir Sveinsson | Use of cgrp antagonist compounds for treatment of psoriasis |
US11517612B2 (en) | 2016-11-18 | 2022-12-06 | Nepsone Ehf | Methods of treating inflammatory skin disorders |
US8168592B2 (en) * | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
DK1957106T4 (da) | 2005-11-14 | 2019-10-28 | Teva Pharmaceuticals Int Gmbh | Antagonist-antistoffer, der er rettet mod calcitonin-gen-relateret peptid og fremgangsmåder til anvendelse af disse |
ES2689322T3 (es) | 2008-03-04 | 2018-11-13 | Teva Pharmaceuticals International Gmbh | Métodos para tratar el dolor crónico |
US8623366B2 (en) | 2009-08-28 | 2014-01-07 | Labrys Biologics, Inc. | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
KR20220130822A (ko) | 2014-03-21 | 2022-09-27 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 칼시토닌 유전자-관련 펩티드에 대한 길항제 항체 및 그의 사용 방법 |
KR101593793B1 (ko) * | 2014-04-29 | 2016-02-12 | 한전케이피에스 주식회사 | 리프트 행거 및 그 리프트 행거를 사용하여 리프트를 설치하는 방법 |
EP3515937A1 (en) | 2016-09-23 | 2019-07-31 | Teva Pharmaceuticals International GmbH | Treating refractory migraine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9201425D0 (sv) * | 1992-05-06 | 1992-05-06 | Kabi Pharmacia Ab | Method and means for preventing constriction of the pupil in the eye |
US5445823A (en) * | 1994-10-20 | 1995-08-29 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith |
-
1995
- 1995-03-28 FR FR9503627A patent/FR2732220B1/fr not_active Expired - Lifetime
-
1996
- 1996-03-04 EP EP96400456A patent/EP0734728B2/fr not_active Expired - Lifetime
- 1996-03-04 DE DE69613168T patent/DE69613168T3/de not_active Expired - Lifetime
- 1996-03-04 ES ES96400456T patent/ES2159697T5/es not_active Expired - Lifetime
- 1996-03-04 AT AT96400456T patent/ATE201828T1/de not_active IP Right Cessation
- 1996-03-26 BR BR9601467A patent/BR9601467A/pt active Search and Examination
- 1996-03-27 MX MX9601151A patent/MX9601151A/es unknown
- 1996-03-27 PL PL96313511A patent/PL313511A1/xx unknown
- 1996-03-27 CA CA002172778A patent/CA2172778C/fr not_active Expired - Lifetime
- 1996-03-27 HU HU9600764A patent/HUP9600764A3/hu unknown
- 1996-03-27 RU RU96105824/14A patent/RU2152785C1/ru active
- 1996-03-27 AR ARP960101927A patent/AR001435A1/es unknown
- 1996-03-27 JP JP8072772A patent/JP3043610B2/ja not_active Expired - Lifetime
- 1996-03-28 US US08/620,805 patent/US5935586A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0734728A1 (fr) | 1996-10-02 |
ATE201828T1 (de) | 2001-06-15 |
DE69613168T2 (de) | 2001-09-27 |
JPH08268904A (ja) | 1996-10-15 |
US5935586A (en) | 1999-08-10 |
EP0734728B2 (fr) | 2008-02-13 |
CA2172778C (fr) | 2008-02-12 |
ES2159697T5 (es) | 2008-07-01 |
BR9601467A (pt) | 1998-03-31 |
FR2732220A1 (fr) | 1996-10-04 |
HUP9600764A3 (en) | 1998-03-02 |
HUP9600764A2 (en) | 1997-06-30 |
HU9600764D0 (en) | 1996-05-28 |
MX9601151A (es) | 1997-02-28 |
EP0734728B1 (fr) | 2001-06-06 |
AR001435A1 (es) | 1997-10-22 |
PL313511A1 (en) | 1996-09-30 |
CA2172778A1 (fr) | 1996-09-29 |
DE69613168T3 (de) | 2009-03-05 |
RU2152785C1 (ru) | 2000-07-20 |
JP3043610B2 (ja) | 2000-05-22 |
DE69613168D1 (de) | 2001-07-12 |
FR2732220B1 (fr) | 1997-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2121461T3 (es) | Utilizacion de un antagonista de cgrp para tratar el eritema cutaneo de origen neurogenico y composicion asi obtenida. | |
ES2154388T3 (es) | Utilizacion de un antagonista de cgrp en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida. | |
ES2081110T3 (es) | Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion. | |
ES2145143T3 (es) | Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel. | |
ES2154503T3 (es) | Composicion cosmetica o dermatologica. | |
BR9407018A (pt) | Copolímeros elastoméricos termoplásticos e composições para o cuidado da pele e do cabelo contendo os mesmos | |
BR9713287A (pt) | Composições de esfingomielinase e seu uso | |
ES2127490T3 (es) | Utilizacion de un aceite rico en acido petroselenico como agente hidratante. | |
ES2117987T3 (es) | Composiciones cosmeticas y usos. | |
ATE311849T1 (de) | Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate | |
CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
ES2159697T3 (es) | Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida. | |
ES2118009T3 (es) | Utilizacion de un antagonista de bradiquinina en una composicion cosmetica, farmaceutica o dermatologica y composicion obtenida. | |
ES2160680T3 (es) | Utilizacion de un antagonista de sustancia p en una composicion farmaceutica. | |
AR017222A1 (es) | Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos | |
HUP9802971A1 (hu) | Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére | |
ES2127613T3 (es) | Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno. | |
DE60216077D1 (de) | Topisches produkt mit visuellem indikator | |
ES2137044T3 (es) | Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica. | |
ES2177098T3 (es) | Utilizacion de goma y de difenildimeticona disuelta en una silicona novolatil de tipo feniltrimeticona para la fabricacion de una composicion cosmetica o farmaceutica, especialmente dermatologica que comprende una fase grasa. | |
ES2163596T3 (es) | Utilizacion de un antagonista de cgrp para el tratamiento de los pruritos y de las disestesias oculares o palpebrales. | |
ES2140175T3 (es) | Utilizacion de la monoetanolamina para preparar una composicion destinada para determinar los cueros cabelludos sensibles. | |
BR0115389A (pt) | Composição cosmética, método cosmético e uso de composição tópica | |
ES2102284T5 (es) | Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion. | |
PT1146886E (pt) | Extracto de soja contendo lipidos processo para a sua producao e composicao farmaceutica ou cosmetica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 734728 Country of ref document: ES |